These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19787230)

  • 61. Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane.
    Bayat Mokhtari R; Baluch N; Morgatskaya E; Kumar S; Sparaneo A; Muscarella LA; Zhao S; Cheng HL; Das B; Yeger H
    BMC Cancer; 2019 Aug; 19(1):864. PubMed ID: 31470802
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
    Bourguignon LYW; Earle C; Shiina M
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Methods to Analyze the Role of Progranulin (PGRN/GEP) on Cancer Stem Cell Features.
    Cheung PFY; Cheung ST
    Methods Mol Biol; 2018; 1806():145-153. PubMed ID: 29956275
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
    Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
    Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells.
    Rybak AP; He L; Kapoor A; Cutz JC; Tang D
    Biochim Biophys Acta; 2011 May; 1813(5):683-94. PubMed ID: 21277911
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Transcriptome Profiling of Panc-1 Spheroid Cells with Pancreatic Cancer Stem Cells Properties Cultured by a Novel 3D Semi-Solid System.
    Yang Z; Zhang Y; Tang T; Zhu Q; Shi W; Yin X; Xing Y; Shen Y; Pan Y; Jin L
    Cell Physiol Biochem; 2018; 47(5):2109-2125. PubMed ID: 29975934
    [TBL] [Abstract][Full Text] [Related]  

  • 67. HepG2 cells acquire stem cell-like characteristics after immune cell stimulation.
    Wang H; Yang M; Lin L; Ren H; Lin C; Lin S; Shen G; Ji B; Meng C
    Cell Oncol (Dordr); 2016 Feb; 39(1):35-45. PubMed ID: 26650484
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance.
    Alvero AB; Chen R; Fu HH; Montagna M; Schwartz PE; Rutherford T; Silasi DA; Steffensen KD; Waldstrom M; Visintin I; Mor G
    Cell Cycle; 2009 Jan; 8(1):158-66. PubMed ID: 19158483
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
    Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
    BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan.
    Emmink BL; Van Houdt WJ; Vries RG; Hoogwater FJ; Govaert KM; Verheem A; Nijkamp MW; Steller EJ; Jimenez CR; Clevers H; Borel Rinkes IH; Kranenburg O
    Gastroenterology; 2011 Jul; 141(1):269-78. PubMed ID: 21459094
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Enhanced expression of stem cell markers and drug resistance in sphere-forming non-small cell lung cancer cells.
    Sun FF; Hu YH; Xiong LP; Tu XY; Zhao JH; Chen SS; Song J; Ye XQ
    Int J Clin Exp Pathol; 2015; 8(6):6287-300. PubMed ID: 26261505
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Role of CD44 and Cancer Stem Cells.
    Wang L; Zuo X; Xie K; Wei D
    Methods Mol Biol; 2018; 1692():31-42. PubMed ID: 28986884
    [TBL] [Abstract][Full Text] [Related]  

  • 73. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 74. STAT3 correlates with stem cell-related transcription factors in cervical cancer.
    Wang H; Cai HB; Chen LL; Zhao WJ; Li P; Wang ZQ; Li Z
    J Huazhong Univ Sci Technolog Med Sci; 2015 Dec; 35(6):891-897. PubMed ID: 26670442
    [TBL] [Abstract][Full Text] [Related]  

  • 75. STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH⁺/CD133⁺ stem cell-like human colon cancer cells.
    Lin L; Fuchs J; Li C; Olson V; Bekaii-Saab T; Lin J
    Biochem Biophys Res Commun; 2011 Dec; 416(3-4):246-51. PubMed ID: 22074823
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.
    Casagrande N; De Paoli M; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D
    Gynecol Oncol; 2013 Dec; 131(3):744-52. PubMed ID: 24029417
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cancer stem cells as a therapeutic target in 3D tumor models of human chondrosarcoma: An encouraging future for proline rich polypeptide‑1.
    Granger CJ; Hoyt AK; Moran A; Becker B; Sedani A; Saigh S; Conway SA; Brown J; Galoian K
    Mol Med Rep; 2020 Nov; 22(5):3747-3758. PubMed ID: 32901865
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification of different gene expressions between diffuse- and intestinal-type spheroid-forming gastric cancer cells.
    Lee JW; Sung JS; Park YS; Chung S; Kim YH
    Gastric Cancer; 2019 Sep; 22(5):967-979. PubMed ID: 30726523
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cancer-initiating cells derived from human rectal adenocarcinoma tissues carry mesenchymal phenotypes and resist drug therapies.
    Fan CW; Chen T; Shang YN; Gu YZ; Zhang SL; Lu R; OuYang SR; Zhou X; Li Y; Meng WT; Hu JK; Lu Y; Sun XF; Bu H; Zhou ZG; Mo XM
    Cell Death Dis; 2013 Oct; 4(10):e828. PubMed ID: 24091671
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
    Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
    Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.